KNC Laboratories Co., Ltd. (6568) Cash flow
Market cap
¥10B
P/E ratio
12.9x
Develops and manufactures specialized organic chemicals for pharmaceutical, electronics, and biotech companies to accelerate their product development.
| 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 836 | 782 | 755 | 803 | 940 | 929 | 919 | 922 | 879 | 1,233 |
| Cash from operations | 1,247 | 2,256 | 1,254 | 42 | 1,327 | 585 | 1,994 | 3,205 | 1,487 | 2,263 |
| Capital expenditures | -493 | -885 | -1,943 | -1,940 | -892 | -833 | -1,130 | -2,352 | -3,300 | -2,626 |
| Cash from investing | 58 | -697 | -2,111 | -1,863 | -660 | -614 | -1,147 | -2,369 | -3,323 | -2,697 |
| Payments for dividends | -60 | -90 | -192 | -193 | -194 | -194 | -272 | -254 | -239 | -255 |
| Repurchases of common stock | - | - | - | -0 | - | - | -112 | -0 | - | -0 |
| Proceeds from issuance of term debt, net | - | - | - | 1,300 | 500 | 400 | - | 1,450 | 1,975 | 1,460 |
| Repayments of term debt | -733 | -680 | -1,279 | -850 | -485 | -367 | -440 | -517 | -826 | -982 |
| Cash from financing | -877 | 2,592 | -1,484 | 255 | -180 | 39 | -523 | 179 | 910 | 222 |